Underwriter |
Biotechnology |
Date Priced |
Offering |
8/20/03 Share |
Offering Gross |
After-Market |
| | ||||||
Adams, |
AtheroGenics Inc. |
1/29/03 |
$6.25 |
$12.89 |
$51.875 |
+106% |
Martek Biosciences |
4/22/03 |
$30.25 |
$49.04 |
$87.725 |
+62% |
|
|
||||||
Banc of |
Amylin Pharmaceuticals |
1/17/03 |
$16.60 |
$25.35 |
$174.96 |
+53% |
|
|
|||||
Bear |
The Medicines Co. |
3/14/03 |
$17.50 |
$28.61 |
$85.75 |
+63% |
|
||||||
Canaccord |
ID Biomedical Corp. |
5/28/03 |
$8.50 |
$12.19 |
$25.5 |
+43% |
|
||||||
C.E. Unterberg, Towbin |
MGI Pharma |
8/8/03 |
$35.50 |
$38.23 |
$181.05 |
+8% |
|
||||||
CIBC World Markets Corp. |
BioMarin |
2/21/03 |
$10 |
$8.18 |
$75 |
-18% |
ID Biomedical |
5/28/03 |
$8.50 |
$12.19 |
$25.5 |
+43% |
|
ILEX Oncology |
7/30/03 |
$17 |
$15.99 |
$93.5 |
-6% |
|
Lexicon Genetics |
7/24/03 |
$5.25 |
$5.15 |
$52.5 |
-2% |
|
The Medicines |
3/14/03 |
$17.50 |
$28.61 |
$85.75 |
+63% |
|
|
||||||
Citigroup |
Esperion |
8/1/03 |
$16 |
$17.16 |
$64 |
+7% |
Martek Biosciences |
4/22/03 |
$30.25 |
$49.04 |
$87.725 |
+62% |
|
|
||||||
Desjardins Securities |
ID Biomedical |
5/28/03 |
$8.50 |
$12.19 |
$25.5 |
+43% |
|
||||||
Deutsche Bank Securities |
Inspire Pharmaceuticals |
3/14/03 |
$13.50 |
$15.50 |
$77.63 |
+15% |
|
||||||
Dlouhy |
ID Biomedical Corp. (Canada; IDBE; |
5/28/03 |
$8.50 |
$12.19 |
$25.5 |
+43% |
|
||||||
Fortis Securities Inc. |
Amylin Pharmaceuticals |
1/17/03 |
$16.60 |
$25.35 |
$174.96 |
+53% |
|
|
|||||
Goldman |
Amylin Pharmaceuticals |
1/17/03 |
$16.60 |
$25.35 |
$174.96 |
+53% |
Exelixis Inc. (EXEL) |
6/20/03 |
$7.10 |
$7.74 |
$80.23 |
+9% |
|
|
||||||
Harris Nesbitt Gerard |
Vicuron Pharmaceuticals |
7/18/03 |
$13.85 |
$13.87 |
$83.1 |
+0% |
|
||||||
Lazard |
AtheroGenics Inc. |
1/29/03 |
$6.25 |
$12.89 |
$51.875 |
+106% |
MGI Pharma Inc. |
8/8/03 |
$35.50 |
$38.23 |
$181.05 |
+8% |
|
Vicuron Pharmaceuticals |
7/18/03 |
$13.85 |
$13.87 |
$83.1 |
+0% |
|
|
||||||
Lehman |
Amylin Pharmaceuticals |
1/17/03 |
$16.60 |
$25.35 |
$174.96 |
+53% |
AtheroGenics Inc. |
1/29/03 |
$6.25 |
$12.89 |
$51.875 |
+106% |
|
Esperion Therapeutics |
8/1/03 |
$16 |
$17.16 |
$64 |
+7% |
|
ILEX Oncology Inc. |
7/30/03 |
$17 |
$15.99 |
$93.5 |
-6% |
|
Onyx Pharmaceuticals |
7/22/03 |
$15.25 |
$16.50 |
$76.25 |
+8% |
|
|
||||||
Merrill |
MGI Pharma Inc. |
8/8/03 |
$35.50 |
$38.23 |
$181.05 |
+8% |
|
||||||
Morgan |
Antigenics |
1/23/03 |
$9.92 |
$12.29 |
$34.22 |
+24% |
|
||||||
Morgan |
Amylin |
1/17/03 |
$16.60 |
$25.35 |
$174.96 |
+53% |
AtheroGenics Inc. |
1/29/03 |
$6.25 |
$12.89 |
$51.875 |
+106% |
|
Cerus Corp. |
6/6/03 |
$9.63 |
$7.38 |
$57.78 |
-23% |
|
Lexicon Genetics Inc. (LEXG) (co-lead) |
7/24/03 |
$5.25 |
$5.15 |
$52.5 |
-2% |
|
Onyx Pharmaceuticals |
7/22/03 |
$15.25 |
$16.50 |
$76.25 |
+8% |
|
The Medicines Co. (MDCO) (co-lead) |
3/14/03 |
$17.50 |
$28.61 |
$85.75 |
+63% |
|
Vicuron Pharmaceuticals |
7/18/03 |
$13.85 |
$13.87 |
$83.1 |
+0% |
|
|
||||||
Needham & Co. |
Antigenics Inc. |
1/23/03 |
$9.92 |
$12.29 |
$34.22 |
+24% |
EPIX Medical Inc. |
8/7/03 |
$15 |
$16.23 |
$64.5 |
+8% |
|
Esperion Therapeutics |
8/1/03 |
$16 |
$17.16 |
$64 |
+7% |
|
Martek Biosciences |
4/22/03 |
$30.25 |
$49.04 |
$87.725 |
+62% |
|
|
||||||
Pacific Growth Equities Inc. |
La Jolla Pharmaceutical |
8/7/03 |
$2.75 |
$3.37 |
$22.4 |
+23% |
Vicuron Pharmaceuticals Inc. (MICU) (co-lead) |
7/18/03 |
$13.85 |
$13.87 |
$83.1 |
+0% |
|
Punk, Ziegel |
Lexicon Genetics |
7/24/03 |
$5.25 |
$5.15 |
$52.5 |
-2% |
|
||||||
RBC Capital Markets |
ID Biomedical Corp. (Canada; IDBE; |
5/28/03 |
$8.50 |
$12.19 |
$25.5 |
+43% |
|
||||||
Ryan Beck & |
Antigenics Inc. |
1/23/03 |
$9.92 |
$12.29 |
$34.22 |
+24% |
|
||||||
S.G. Cowen Securities Corp. |
BioMarin |
2/21/03 |
$10 |
$8.18 |
$75 |
-18% |
EPIX Medical |
8/7/03 |
$15 |
$16.23 |
$64.5 |
+8% |
|
Esperion |
8/1/03 |
$16 |
$17.16 |
$64 |
+7% |
|
Exelixis |
6/20/03 |
$7.10 |
$7.74 |
$80.23 |
+9% |
|
Onyx Pharmaceuticals |
7/22/03 |
$15.25 |
$16.50 |
$76.25 |
+8% |
|
|
||||||
TD Securities |
ID Biomedical |
5/28/03 |
$8.50 |
$12.19 |
$25.5 |
+43% |
|
||||||
UBS Securities |
Antigenics Inc. |
1/23/03 |
$9.92 |
$12.29 |
$34.22 |
+24% |
BioMarin |
2/21/03 |
$10 |
$8.18 |
$75 |
-18% |
|
ILEX Oncology Inc. (ILXO) (lead) |
7/30/03 |
$17 |
$15.99 |
$93.5 |
-6% |
|
Lexicon Genetics Inc. (LEXG) (co-lead) |
7/24/03 |
$5.25 |
$5.15 |
$52.5 |
-2% |
|
|
||||||
U.S. Bancorp Piper Jaffray |
Esperion |
8/1/03 |
$16 |
$17.16 |
$64 |
+7% |
ILEX Oncology Inc. (ILXO) |
7/30/03 |
$17 |
$15.99 |
$93.5 |
-6% |
|
Inspire Pharmaceuticals |
3/14/03 |
$13.50 |
$15.50 |
$77.63 |
+15% |
|
MGI Pharma Inc. |
8/8/03 |
$35.50 |
$38.23 |
$181.05 |
+8% |
|
|
||||||
Wells Fargo Securities |
EPIX Medical |
8/7/03 |
$15 |
$16.23 |
$64.5 |
+8% |
ID Biomedical |
5/28/03 |
$8.50 |
$12.19 |
$25.5 |
+43% |
|
|
||||||
WR Hambrecht + Co. |
EPIX Medical |
8/7/03 |
$15 |
$16.23 |
$64.5 |
+8% |
|
||||||
|
| ||||||
Notes: | ||||||
* The financings in this chart are for public offerings in the U.S. only. The data were compiled primarily from BioWorld Financial Watch's monthly financing charts covering the period from Jan. 1 to Aug. 20, 2003. Those charts were published on Feb. 10, March 10, April 7, May 5, June 9, July 7 and Aug. 4, 2003. The gross proceed totals listed reflect only those shares sold by companies. They include money raised through overallotment options, when disclosed. | ||||||
** Offering price per share is adjusted to reflect any post-offering splits. | ||||||
All prices and totals in U.S. dollars. Unless otherwise noted, shares are traded on the Nasdaq exchange. | ||||||
TSE = Toronto Stock Exchange. | ||||||
